Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
STATEMENT ON BAUSCH HEALTH RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES
-
As Drugmakers Cut Off Discounts, Providers Fret for Low-Income Patients
-
HRSA DIRECTS UCB TO RESTORE 340B PRICING TO SAFETY-NET HOSPITALS
-
340B HOSPITALS REMAIN ON THE FRONT LINES OF THE NATIONAL CAMPAIGN TO PURSUE HEALTH EQUITY
-
U.S. SUPREME COURT STRIKES DOWN MEDICARE CUTS TO 340B HOSPITALS
-
340B HEALTH BOARD ELECTS THREE NEW MEMBERS
-
FIVE HOSPITAL ASSOCIATIONS URGE APPEALS COURTS TO BACK 340B ENFORCEMENT
-
FINANCIAL LOSSES FROM DRUG COMPANIES’ 340B RESTRICTIONS HAVE MORE THAN DOUBLED SINCE THE END OF 2021
-
STATEMENT ON GOVERNMENT APPEAL OF COURT DECISION IN ASTRAZENECA 340B CONTRACT PHARMACY LAWSUIT
-
STUDY DEMONSTRATES ESSENTIAL ROLE OF 340B AMID COVID-19 CHALLENGES AND DRUG COMPANY RESTRICTIONS
-
BOEHRINGER INGELHEIM REFERRED FOR PENALTIES FOR CONTINUED VIOLATIONS OF FEDERAL LAW ON 340B PRICING
-
Hospital groups worry as more drugmakers limit 340B discounts